The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...

The study aims to assess the Catheter and Affera system in patients who have ventricular tachycardia (VT) due to scarring ...

Imricor Medical Systems (ASX:IMR) is racing through regulatory initiatives supporting new device approvals in the US and ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Ablation of cardiac arrhythmias in children under 18 years of age without the use of fluoroscopy is an effective procedure, ...

A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex ...

The Global Electrophysiology Market Size is projected to grow at a CAGR of 9.62% from 2024 to 2031, according to a new report ...

A multicenter study led by Hospital Clínico San Carlos and the CNIC has validated a new preoperative planning method using ...

NDAQ:ADGM) Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias ...

However, the catheter icon (sinoatrial) identifies the site of successful ablation of the tachycardia. The value of the electroanatomical mapping was seen in this case to be 2.16 cm between the ...

Pulsed-field ablation (PFA) with a system encompassing the Varipulse catheter and Trupulse ... In addition, freedom from recurrent atrial fibrillation, tachycardia, or flutter after blanking was 75.4% ...

To study the complications and effectiveness of the treatment of chronic arrhythmias with cardiac Ganglion Plexus (GP) ablation, and to explore the value of the treatment of chronic arrhythmias with ...